Regulation of cellular pathways in human brain development
Project Number5P01NS083513-07
Contact PI/Project LeaderALVAREZ-BUYLLA, ARTURO
Awardee OrganizationUNIVERSITY OF CALIFORNIA, SAN FRANCISCO
Description
Abstract Text
The mechanisms that regulate the production and migration of human interneurons (IN) and glial sub-types and the functional integration into neural circuits during perinatal stages remains poorly understood. These processes are likely disrupted in neonatal neurological injuries, which can result in severe long-term cognitive disabilities and high social and financial burden. The proposed program will investigate the developmental origins, diversity and cellular interactions of IN, OPCs and microglia using post-mortem human brain tissue and rodent experimental systems. Key past findings include: (i) Discovery of extensive postnatal migration of INs to specialized cortical regions, suggesting that formation of neural circuits takes place over a protracted period (Paredes, Science; Sorrels, Nature); (ii) that the HIF pathway is a critical regulator of oligodendrocyte precursor cell (OPC) maturation and that OPCs under hypoxic conditions become angiogenic in cortical white matter (Yuen, Cell). Our results indicated that OPCs use vasculature as a scaffold to traffic through the developing brain (Tsai, Science), and (iii) that ins migrate in clusters along large vessels in human neonatal brain (Paredes, Science). For the competing renewal we have expanded the investigator team under direction of Arturo Alvarez- Buylla to recruit promising junior investigators (Mercedes Paredes, Steve Fancy, Tom Nowakowski) and new Project Leader Xian Piao. Project 1 investigates origins and diversity of migrating young INs to human newborn cortex and amygdala. Project 2 investigates the mechanisms underlying angiogenesis and IN migration along the blood vessels in human developing cortex and HIE. Project 3 will provide evidence for microglial-encoded GPR56 pathway function in regulation of IN maturation. The administrative core (A) provides budgetary oversight, coordination and access to resources. All projects will use postmortem neonatal human neuropathological specimens supported by a neuropathology core (B) and transcriptomic core (C) to support studies in cellular diversity (Velmeshev, Science; Schirmer, Nature). The studies are intended to reveal cellular and genetic mechanisms impacted by neonatal brain injury and congenital neurogenetic disease.
Public Health Relevance Statement
The project is intended to provide a new understanding of neuronal and glial development during late gestation and the early postnatal period. These are critical times in human neonatal brain development that are vulnerable to injuries, such as hypoxia, and can result in lifelong neuro-cognitive disabilities, including cerebral palsy and epilepsy.
National Institute of Neurological Disorders and Stroke
CFDA Code
853
DUNS Number
094878337
UEI
KMH5K9V7S518
Project Start Date
01-July-2014
Project End Date
30-April-2025
Budget Start Date
01-May-2021
Budget End Date
30-April-2022
Project Funding Information for 2021
Total Funding
$1,332,373
Direct Costs
$824,999
Indirect Costs
$507,374
Year
Funding IC
FY Total Cost by IC
2021
National Institute of Neurological Disorders and Stroke
$1,332,373
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5P01NS083513-07
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5P01NS083513-07
Patents
No Patents information available for 5P01NS083513-07
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5P01NS083513-07
Clinical Studies
No Clinical Studies information available for 5P01NS083513-07
News and More
Related News Releases
No news release information available for 5P01NS083513-07
History
No Historical information available for 5P01NS083513-07
Similar Projects
No Similar Projects information available for 5P01NS083513-07